USD 13.29
(8.92%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 262.7 Million USD | 37.92% |
2022 | 207.3 Million USD | 1.82% |
2021 | 203.6 Million USD | -3.51% |
2020 | 211 Million USD | 117.75% |
2019 | 96.9 Million USD | -63.8% |
2018 | 267.7 Million USD | 8.03% |
2017 | 247.8 Million USD | 60.91% |
2016 | 154 Million USD | -33.16% |
2015 | 230.4 Million USD | 5.25% |
2014 | 218.9 Million USD | -28.84% |
2013 | 307.6 Million USD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 76.3 Million USD | -50.51% |
2024 Q2 | 74.6 Million USD | -2.23% |
2023 Q4 | 154.16 Million USD | 112.06% |
2023 Q3 | 72.7 Million USD | -44.5% |
2023 Q2 | 131 Million USD | 90.96% |
2023 FY | 285.9 Million USD | 37.92% |
2023 Q1 | 68.6 Million USD | -42.58% |
2022 Q3 | 63.45 Million USD | -42.05% |
2022 Q2 | 109.5 Million USD | 85.28% |
2022 FY | 207.3 Million USD | 1.82% |
2022 Q1 | 59.1 Million USD | -25.22% |
2022 Q4 | 119.47 Million USD | 88.3% |
2021 Q3 | 46.2 Million USD | -67.09% |
2021 FY | 203.6 Million USD | -3.51% |
2021 Q4 | 79.02 Million USD | 71.06% |
2021 Q2 | 140.4 Million USD | 102.16% |
2021 Q1 | 69.45 Million USD | -37.91% |
2020 Q2 | 119.7 Million USD | 100.5% |
2020 Q3 | 52.75 Million USD | -55.93% |
2020 Q4 | 111.85 Million USD | 112.06% |
2020 Q1 | 59.7 Million USD | -52.11% |
2020 FY | 211 Million USD | 117.75% |
2019 Q2 | 95 Million USD | 100.0% |
2019 Q1 | 47.5 Million USD | -38.07% |
2019 Q3 | 59.7 Million USD | -37.16% |
2019 FY | 96.9 Million USD | -63.8% |
2019 Q4 | 124.65 Million USD | 108.8% |
2018 FY | 267.7 Million USD | 8.03% |
2018 Q4 | 76.7 Million USD | 0.0% |
2018 Q3 | 76.7 Million USD | 20.41% |
2018 Q2 | 63.7 Million USD | 0.0% |
2018 Q1 | 63.7 Million USD | -28.55% |
2017 Q1 | 51.4 Million USD | -17.03% |
2017 Q2 | 51.4 Million USD | 0.0% |
2017 Q3 | 89.15 Million USD | 73.44% |
2017 Q4 | 89.15 Million USD | 0.0% |
2017 FY | 247.8 Million USD | 60.91% |
2016 Q1 | 58.6 Million USD | -2.01% |
2016 Q4 | 61.95 Million USD | 0.0% |
2016 Q2 | 21.2 Million USD | -63.82% |
2016 Q3 | 61.95 Million USD | 192.22% |
2016 FY | 154 Million USD | -33.16% |
2015 Q2 | 65.59 Million USD | 8.61% |
2015 Q4 | 59.8 Million USD | -16.48% |
2015 FY | 230.4 Million USD | 5.25% |
2015 Q1 | 60.4 Million USD | 4.5% |
2015 Q3 | 71.6 Million USD | 9.15% |
2014 Q1 | 61.4 Million USD | -37.79% |
2014 Q3 | 95 Million USD | 13.23% |
2014 Q4 | 57.8 Million USD | -39.16% |
2014 FY | 218.9 Million USD | -28.84% |
2014 Q2 | 83.9 Million USD | 36.64% |
2013 Q2 | 86.3 Million USD | 47.02% |
2013 FY | 307.6 Million USD | 0.0% |
2013 Q1 | 58.7 Million USD | 0.0% |
2013 Q3 | 101.1 Million USD | 17.15% |
2013 Q4 | 98.7 Million USD | -2.37% |
Name | Operating Income | Operating Income Difference |
---|---|---|
American Medical Technologies Inc. | 1.16 Million USD | -22464.464% |
Ansell Limited | 129.3 Million USD | -103.171% |
Ansell Limited | 129.3 Million USD | -103.171% |
BG Medicine, Inc. | - USD | -Infinity% |
Biotage AB (publ) | 31.13 Million USD | -743.659% |
BioLife Sciences Inc. | - USD | -Infinity% |
CB Scientific, Inc. | -1.59 Million USD | 16562.984% |
Psykey, Inc. | -797.5 Thousand USD | 33040.274% |
ConvaTec Group Plc | 262.7 Million USD | 0.0% |
Encision Inc. | -640.78 Thousand USD | 41096.718% |
Golden Valley Development, Inc | -141.81 Thousand USD | 185347.867% |
Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 239070.254% |
Innovative MedTech Inc. | -4.27 Million USD | 6246.358% |
LifePoint, Inc. | -7.49 Million USD | 3604.897% |
Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 4154.012% |
Paradigm Medical Industries, Inc. | 330 Thousand USD | -79506.061% |
QuantRx Biomedical Corporation | - USD | -Infinity% |
Remedent, Inc. | -122.89 Thousand USD | 213868.411% |
Reflect Scientific, Inc. | -467.27 Thousand USD | 56319.21% |
SmileDirectClub, Inc. | -241.15 Million USD | 208.934% |
Sector 10, Inc. | -39.84 Thousand USD | 659421.353% |
Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | 17.805% |
SheerVision, Inc. | 155.72 Thousand USD | -168593.731% |
United Health Products, Inc. | -2.42 Million USD | 10926.119% |
Vasamed, Inc. | 4.74 Million USD | -5439.504% |
Wearable Health Solutions, Inc. | -2.29 Million USD | 11550.909% |
Yubo International Biotech Limited | -1.2 Million USD | 21896.796% |